Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.
Flynn NM; Forthal DN; Harro CD; Judson FN; Mayer KH; Para MF; The Journal Of Infectious Diseases, 2005, vol. 191, issue 5, p 654, ISSN 00221899. ISBN 00221899.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via Electronic Journal Services